Open Fellowship

AFTD Holloway Postdoctoral Fellowship 2027: $65,000 a Year for Two Years of Frontotemporal Degeneration Research

The Association for Frontotemporal Degeneration’s 2027 Holloway Postdoctoral Fellowship offers eligible U.S. and international FTD researchers $65,000 per year for two years. The September 2 letter-of-intent deadline has passed; applicants invited by AFTD may submit a full proposal by November 20, 2026.

FindMyMoney.App
Published by FindMyMoney.App
Official source: Association for Frontotemporal Degeneration
đź’° Funding $65,000 per year for two years, or $130,000 total; up to two fellowships will be awarded
đź“… Deadline Nov 20, 2026
📍 Location International and Postdoctoral appointment at an academic institution, teaching hospital, or nonprofit research institute
🏛️ Source Association for Frontotemporal Degeneration

AFTD Holloway Postdoctoral Fellowship 2027: $65,000 a Year for Two Years of Frontotemporal Degeneration Research

AFTD lists its 2027 Holloway Postdoctoral Fellowship cycle as open, but the public letter-of-intent (LOI) stage has closed. The only remaining submission stage is the full proposal, and it is limited to applicants AFTD invites after reviewing their LOIs. The published deadline for those invited applicants is November 20, 2026. The award supports research focused on frontotemporal degeneration (FTD) with $65,000 per year for two years, or $130,000 total, during the funding period from July 1, 2027, through June 30, 2029. AFTD expects to make up to two awards. Someone who did not submit an LOI should not treat this as an open application window or assume they can enter at the full-proposal stage.

The LOI deadline was September 2, 2026, at 8:00 p.m. Eastern Time. AFTD’s schedule places invitations at approximately October 4, 2026, and gives invited applicants until November 20, 2026, at 8:00 p.m. Eastern Time to submit a full proposal. The AFTD portal remains open for the 2027 cycle, but that does not reopen the LOI stage: the RFP says the top LOI proposals will be invited to submit the full application. The published materials do not describe a late LOI or direct full-application route. Anyone who did not submit an LOI should contact AFTD to ask about future cycles, rather than treat the November deadline as an open call.

This fellowship is intended for early-career investigators who have a doctorate and an eligible postdoctoral appointment, including international researchers. Its scope covers basic, translational, and clinical FTD research, as well as FTD outcomes research and public health. A proposal must be about FTD itself. A project focused entirely on another neurodegenerative disease will not qualify simply because it uses related methods or could eventually have broader relevance.

Key details

DetailConfirmed information
Opportunity2027 AFTD Holloway Postdoctoral Fellowship
FunderAssociation for Frontotemporal Degeneration, through the Holloway Family Fund
Award$65,000 per year for two years; $130,000 total
Number of awardsUp to two fellowships
Funding periodJuly 1, 2027 to June 30, 2029
Current stageLOI closed; AFTD expects to invite selected applicants around October 4; only invitees may submit a full proposal
LOI deadlineSeptember 2, 2026, by 8:00 p.m. Eastern Time
Full proposal deadlineNovember 20, 2026, by 8:00 p.m. Eastern Time, for invited applicants
Expected LOI invitationsAround October 4, 2026
Decision lettersApril 2027
Applicant geographyU.S. and international postdoctoral investigators
Eligible settingAcademic institution, teaching hospital, or nonprofit research institute
Main use of fundsRecipient stipend or salary and benefits; justified direct costs may be considered
Official sourceAFTD Holloway Fellowships

The amount should not be read as an unrestricted research budget. AFTD says the award is primarily intended to cover the fellow’s stipend or salary and benefits. Other expenses, such as research costs, travel to scientific meetings, publication costs, or technical staff support, may be considered when they are itemized and justified. The RFP also states that the funds are for direct costs and cannot be allocated to institutional overhead.

What the fellowship supports

FTD is an umbrella term for a group of neurodegenerative disorders affecting behavior, language, movement, and cognition. The 2027 RFP names behavioral variant FTD, primary progressive aphasia, progressive supranuclear palsy, corticobasal degeneration, and FTD-ALS as examples within the program’s scope. Applicants do not need to force a project into one narrow subtype, but the connection to FTD should be unmistakable in the research question, methods, expected findings, and likely value to the field.

AFTD lists several areas of need. These include cellular and molecular mechanisms involved in FTD pathogenesis; models that reproduce FTD pathology or clinical phenotype; technologies for diagnosis, disease monitoring, symptom or disease treatment, and caregiver support; bioinformatics and computational biology; fluid, imaging, or digital biomarker development; and work addressing health disparities or the needs of populations underrepresented in FTD research.

That list is illustrative rather than a closed set. The RFP says that projects may address any area of basic, translational, or clinical FTD research, as well as outcomes research and public health. The practical test is whether the proposal makes a clear and credible contribution to understanding, diagnosing, monitoring, treating, or responding to FTD. A technically impressive project with only a remote connection to FTD is a weaker fit than a focused project that answers a meaningful FTD question with an appropriate method.

The fellowship also comes with a potential research-resource benefit through AFTD’s collaboration with Target ALS. AFTD postdoctoral fellows may be able to access core resources for post-mortem brain tissue, human stem cells, and viral vectors, with most associated costs covered by Target ALS. Access is not automatic: recipients who want to use the resources must submit a written request explaining how they fit the funded research and provide proof of AFTD funding. These resources can be relevant to a proposal, but applicants should not promise access before confirming that their project and requested materials fit the available core facilities.

Who can apply

The basic eligibility requirements are unusually clear. An applicant must hold a PhD, MD, or similar doctorate degree and be engaged in postdoctoral research at an academic institution, teaching hospital, or nonprofit research institute. AFTD welcomes both U.S. and international postdoctoral investigators. The application instructions also allow current PhD candidates to apply if they will begin a postdoctoral appointment at a not-for-profit institution no later than July 1, 2027.

The postdoctoral appointment must last through the entire two-year funding period. Someone whose current appointment ends before June 30, 2029 must have a documented plan for an eligible appointment that covers the full period. The program allows applicants to be entering the first, second, or third year of a postdoctoral appointment at the start of the fellowship term, provided the appointment continues for the required duration.

The program excludes people who hold temporary or permanent staff scientist positions rather than postdoctoral appointments. That distinction is important for researchers who have recently moved into a staff role or whose institution uses nonstandard titles. If your title does not clearly identify you as a postdoctoral researcher, ask the sponsoring institution or AFTD whether the appointment satisfies the program’s definition before preparing a full application.

The proposed research must specifically focus on FTD. AFTD says proposals focused entirely on other neurodegenerative diseases will not be considered. This does not prevent comparative, cross-disease, or methodologically broad work, but the FTD rationale should be central rather than added in the final paragraph. The application should make clear which FTD population, mechanism, clinical problem, or care need the project addresses.

How the application works

The 2027 process uses AFTD’s online submission portal. AFTD labels the cycle open and the portal is available, but the public LOI stage closed on September 2. AFTD says it will notify LOI applicants four to five weeks after the deadline about whether they are invited to submit a full application; the RFP estimates invitations around October 4. Only those selected after confidential LOI review should proceed to the full proposal. A new portal account, eligibility quiz, or email to AFTD does not substitute for the closed LOI or an invitation. If you submitted an LOI, watch for AFTD’s decision and use the portal’s instructions if invited. If you did not submit one, the published process provides no way to enter this round now; contact [email protected] about future opportunities instead.

For reference, AFTD required the following LOI components in a single PDF; this submission stage is closed:

  • An applicant CV or NIH-formatted biosketch, with a five-page maximum.
  • A description of the proposed research, consisting of one page of specific aims and up to one additional page for references.
  • A one-page statement of interest in FTD research.

The specific-aims page should include background, rationale, proposed experiments divided into two or three aims, methods, and the resources and data needed to complete the work. The statement of interest is deliberately more personal. It should explain why the applicant is interested in FTD research, describe future career plans, and identify relevant preliminary data if it helped lead to the proposed project.

LOIs are reviewed confidentially by AFTD staff. The RFP identifies four screening categories: novelty and significance, feasibility, investigator, and interest in FTD. The strongest LOI will therefore do more than list an interesting hypothesis. It will show why the question matters to FTD research, why the proposed work can be completed in two years, why the applicant and lab have the necessary expertise or collaborations, and why the applicant is likely to remain committed to the field.

Applicants invited to the second stage complete a substantially larger submission. The full application includes a current CV or biosketch, institutional certification and endorsement, a 250-word lay abstract, a four-page research plan, a budget, a signed mentor sponsorship letter and training-plan description, the sponsoring principal investigator’s CV or biosketch, a summary of the PI’s current funding, and two independent letters of support. Human-subjects and animal-use statements are also required where relevant, although the relevant approval may be pending at the time of submission.

Timeline and deadline strategy

The LOI deadline has passed and cannot serve as a new entry point in the published process. AFTD lists November 20, 2026, at 8:00 p.m. Eastern as the full-proposal deadline for applicants invited after LOI review. This is a deadline for the remaining stage of an active cycle, not a public deadline that makes the opportunity newly available to applicants who missed the LOI. The schedule estimates invitations around October 4. If you submitted an LOI, monitor email, including spam, and the portal for AFTD’s decision and any full-application instructions. If you did not submit an LOI, the RFP does not offer a late-entry route or allow applicants to skip directly to the full proposal; contact AFTD about future opportunities instead.

The published cycle is:

  1. The RFP opened July 8, 2026.
  2. The LOI deadline was September 2, 2026, by 8:00 p.m. Eastern; this stage is closed.
  3. Invitations for full proposals are expected around October 4, 2026.
  4. Invited full proposals are due November 20, 2026, by 8:00 p.m. Eastern.
  5. Decision letters are expected in April 2027.
  6. The two-year funding period begins July 1, 2027 and ends June 30, 2029.

For invited applicants, the full-proposal deadline leaves limited time to assemble institutional approvals, new collaborations, or access to specialized samples. Begin those conversations as soon as an invitation arrives. A realistic research-plan outline, draft budget, mentor commitment, and confirmed independent references can make the remaining submission period manageable.

What invited applicants should carry forward from the LOI

The LOI stage is closed. For applicants invited to the full proposal, the same scientific case now needs to be expanded within the four-page research plan. Start by reducing the project to one FTD-specific question. The one-page aims document cannot carry a broad program of loosely connected experiments. Each aim should have a purpose, a method, and a result that will change what the field knows or can do. If an aim depends on another aim, explain that dependency and identify a credible fallback. Reviewers are looking for a project that is ambitious but not fragile.

Make the two-year scope visible. The RFP’s feasibility criterion asks whether the project is achievable within the fellowship period and whether the resources or models are appropriate. A short work plan can help even if the page limit does not permit a full schedule: show what will be established first, what data will be generated next, and what analysis or validation will complete the work. Do not imply that every experiment will work exactly as planned. Instead, show that the project has an interpretable decision point if a method or model fails.

Connect the investigator to the project without turning the CV into a publication inventory. The application instructions ask for a CV or biosketch, while the review criteria emphasize career-stage-appropriate achievement and capacity for independent research. Select evidence that demonstrates relevant technical skills, disease knowledge, quantitative ability, or collaboration. If the project asks you to learn a new method, identify the mentor, collaborator, or training environment that will supply that expertise.

Use the statement of interest to explain commitment rather than repeat the specific aims. AFTD wants to know why the applicant is drawn to FTD and whether the fellowship will support a continuing career in the field. A concise account of an experience, result, or unmet clinical or research problem can be more useful than a generic declaration that FTD research is important. If preliminary data motivated the project, describe what it actually showed and what remains unknown; do not treat preliminary evidence as proof of the final hypothesis.

Write for a scientifically informed reader who may not work in your exact subfield. Define specialized terms, state the clinical or biological stakes early, and make the connection between each method and the FTD question explicit. A reviewer should not have to infer why an assay, dataset, animal model, imaging measure, or computational pipeline matters to people affected by FTD.

Full proposal materials to arrange early

The full application has several institutional dependencies. The sponsoring PI must provide a signed letter describing the two-year training plan, its relationship to the applicant’s career goals, the path toward independent research, and the plan for maintaining a commitment to FTD. The PI must also provide a CV or biosketch and a current-funding summary that lists each award’s source, title, dates, and amount.

The applicant must obtain institutional certification and endorsement. Send that form to the appropriate sponsored-research or grant-administration office early enough for institutional review. A budget template is supplied through the portal. Because the award is primarily for stipend or salary and benefits, every request for travel, research, publication, or technical support should be itemized and justified. Institutional overhead is not an eligible allocation under the RFP.

Two independent professional contacts must submit letters of support. They cannot be the PI who will mentor and oversee the project. AFTD gives examples such as a graduate thesis advisor, a collaborator in another lab, or an investigator who supervised an independent project. Invited applicants should contact likely references as soon as possible. The application instructions state that the full application is incomplete until both letters have arrived, so a reference who agrees in principle but misses the portal request can still create a serious problem.

If the research involves human participants or vertebrate animals, document the IRB or IACUC status. Approval may be pending at submission, but the application should say what review is required and where the protocol stands. Also begin thinking about data management and sharing. AFTD expects a concise plan covering data types, tools and code, standards, preservation and access, reuse constraints, and oversight. The plan should be realistic about consent, licensing, privacy, and proprietary restrictions rather than promising unrestricted release of materials that cannot legally be shared.

Common mistakes to avoid

The most serious mistake is a weak disease fit. A project may use an advanced technique or address a general neurodegenerative mechanism, but that does not make it an FTD proposal. Put the FTD population, mechanism, or unmet need at the center of the question and explain how the proposed evidence will advance that area.

A common weakness in an LOI is treating it as a miniature full proposal with no coherent story. The first stage was short by design. Its page limits were best used to show significance, a small number of testable aims, appropriate methods, and a credible investigator-development rationale. Invited applicants should carry that clear logic into the fuller research plan instead of adding secondary experiments that obscure the central question.

For applicants who submitted an LOI and receive an invitation, do not assume that a postdoctoral title automatically proves eligibility. Confirm that the appointment continues through June 30, 2029 and that the host is an academic institution, teaching hospital, or nonprofit research institute. Staff scientist appointments are excluded. Current PhD candidates should document how and when the eligible postdoctoral appointment will begin.

Finally, do not budget as if the $130,000 total were a flexible project grant. The stated primary purpose is stipend or salary and benefits, and the funds are direct costs only. A carefully justified budget that respects those limits is more credible than a long list of purchases that the program does not promise to support. Also check for overlapping fellowships or grants: the RFP says Holloway recipients cannot hold two fellowships or grants concurrently and must report an overlap to AFTD.

Frequently asked questions

Can international researchers apply?

Yes. AFTD explicitly welcomes U.S. and international postdoctoral investigators. The host appointment still must be at an academic institution, teaching hospital, or nonprofit research institute, and it must cover the full funding period.

Can someone submit an LOI now?

No. The LOI deadline was September 2, 2026, at 8:00 p.m. Eastern. AFTD expects to invite selected applicants around October 4, 2026. Only invited applicants may submit a full proposal, due November 20, 2026, at 8:00 p.m. Eastern.

Can a current PhD candidate apply?

Yes, if the candidate will begin a postdoctoral appointment at a not-for-profit institution no later than July 1, 2027 and will have an appointment lasting through the full two-year funding period.

Is a project about another neurodegenerative disease eligible?

Not if it is focused entirely on another disease. The RFP requires a specific FTD focus. Comparative or cross-disease work needs a clear, central FTD rationale.

Can the award pay research expenses?

Possibly, but salary or stipend and benefits are the primary use. Other direct expenses may be considered when itemized and justified in the budget. Institutional overhead is not eligible.

Are there limits on other funding?

Yes. The RFP says recipients cannot hold two fellowships or grants concurrently and must spend the majority of their time on the funded research. Report a potential overlap to AFTD rather than assuming the awards can be combined.

Begin with AFTD’s official Holloway Fellowships page, which contains the current cycle dates, award details, submission portal, RFP, and application instructions. Read the 2027 Holloway Postdoctoral Fellowship RFP for the scope and review criteria, then read the application instructions for the invited full application requirements.

Applicants who receive an invitation should verify the appointment dates with the host institution, read the full application instructions, prepare the four-page research plan and 250-word lay abstract, and arrange institutional endorsement, budget details, mentor documentation, and two independent support letters well before November 20. Questions about scientific scope or review can be sent to Kate Still at [email protected]; questions about application materials or the portal can be sent to Samantha Garner at [email protected]. A focused, FTD-specific full proposal should make the novelty, feasibility, investigator fit, training environment, and commitment to the field clear. If no invitation arrives, ask AFTD whether one was issued and do not treat the November deadline as open to all applicants.

Next step
Apply Now